Tabula Rasa HealthCare, Inc. Quarterly Selling and Marketing Expense in USD from Q3 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Tabula Rasa HealthCare, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q3 2015 to Q2 2023.
  • Tabula Rasa HealthCare, Inc. Selling and Marketing Expense for the quarter ending June 30, 2023 was $2.73M, a 25.8% increase year-over-year.
  • Tabula Rasa HealthCare, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2023 was $10.9M, a 4.84% increase year-over-year.
  • Tabula Rasa HealthCare, Inc. annual Selling and Marketing Expense for 2022 was $10.5M, a 4.96% decline from 2021.
  • Tabula Rasa HealthCare, Inc. annual Selling and Marketing Expense for 2021 was $11M, a 35.5% increase from 2020.
  • Tabula Rasa HealthCare, Inc. annual Selling and Marketing Expense for 2020 was $8.15M, a 67.8% decline from 2019.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $10.9M $2.73M +$560K +25.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $10.3M $2.45M -$196K -7.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $10.5M $2.81M -$1K -0.04% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-10
Q3 2022 $10.5M $2.86M +$138K +5.08% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $10.4M $2.17M -$367K -14.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $10.7M $2.65M -$318K -10.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $11M $2.81M +$10.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $773K $2.72M -$2.31M -45.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $3.08M $2.54M -$2.49M -49.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $5.57M $2.97M -$2.57M -46.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $8.15M -$7.45M -$14.1M -212% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-10
Q3 2020 $22.3M $5.03M -$1.85M -26.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $24.1M $5.03M -$1.84M -26.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $26M $5.54M +$690K +14.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $25.3M $6.67M +$3.99M +149% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $21.3M $6.88M +$4.22M +158% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $17.1M $6.87M +$4.56M +197% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $12.5M $4.85M +$2.85M +142% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $9.67M $2.68M +$1.01M +60.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $8.66M $2.67M +$1.34M +101% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $7.31M $2.31M +$1M +76.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $6.31M $2M +$772K +62.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $5.54M $1.67M +$324K +24% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $5.22M $1.33M +$444K +50.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $4.77M $1.31M +$454K +52.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $4.32M $1.23M +$460K +59.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $3.86M $1.35M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $881K +$178K +25.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $860K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $770K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q3 2015 $703K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.